Search Results 31-40 of 17660 for Pemphigoid

  1. Reese L. Imhof, M.D. - Doctors and Medical Staff - Mayo Clinic

    Conditions treated · Acne · Alopecia areata · Bullous disease · Bullous pemphigoid · Contact dermatitis · Cutaneous lupus · Dermatitis · Dermatitis herpetiformis ...

  2. Aaron R. Mangold, M.D. - Mayo Clinic Faculty Profiles

    Bullous pemphigoid. Pityriasis rubra pilaris. Dermatomyositis. To streamline, scale and automate his research, he develops and leverages advanced genomic ...

  3. Shruti Agrawal, M.D. - Doctors and Medical Staff - Mayo Clinic

    Agrawal is active in research and education. Conditions treated · Bullous pemphigoid; Connective tissue disorder; Dermatitis · Lymphoma · Pemphigus · Psoriasis ...

  4. Autoimmune Diseases Clinical Trials - Mayo Clinic Research

    Recently, Interleukin (IL)-17 has been identified as a key driver of chronic inflammation in Bullous Pemphigoid (BP). Ixekizumab is a recombinant high ...

  5. Epidermolysis bullosa - Symptoms and causes - Mayo Clinic

    Pemphigoid disorders. Mayo Clinic; 2021. Pope E, et al. A consensus approach to wound care in epidermolysis bullosa. Journal of the American Academy of ...

  6. Jenny L. Link, M.D. - Doctors and Medical Staff - Mayo Clinic

    Bullous pemphigoid · Cutaneous b-cell lymphoma; Cutaneous lupus; Dermatitis; Dermatitis herpetiformis; Dermatomyositis · Lupus; Mucous membrane disorder ...

  7. Empagliflozin and linagliptin (oral route) - Side effects & dosage - Mayo Clinic

    This medicine may cause bullous pemphigoid. Tell your doctor if you have large, hard skin blisters while using this medicine. Make sure any doctor or ...

  8. Publications - Shruti Agrawal, M.D. - Mayo Clinic

    ... pemphigoid and pemphigus diseases: A retrospective study of 278 cases. J Am Acad Dermatol. 2024 Dec 17 [Epub ahead of print] View PubMed; Agrawal S, Ameline ...

  9. A Study of PRN1008 in Patients With Pemphigus - Mayo Clinic

    The purpose of this study is to evaluate the effectiveness and safety of oral PRN1008 in moderate to severe pemphigus. Participation eligibility. Participant ...

  10. A Study to Evaluate the Effectiveness, Safety and Tolerability of Efgatigimod PH20 SC in Adults with Pemphigus - Mayo Clinic

    The primary purpose of this study is to demonstrate the effectiveness of efgartigimod PH20 SC compared to placebo in the treatment of patients with Pemphigus ...